Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
JCO Global Oncology
|
September 26, 2022
Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update
Surendra S Shastri, Sarah Temin, Maribel Almonte, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study
Naren Babu, Shakuntala Mahilkar, Anup Jayaram, et al.
The New England Journal of Medicine
|
April 3, 2009
HPV screening for cervical cancer in rural India
Rengaswamy Sankaranarayanan, Bhagwan M Nene, Surendra S Shastri, et al.
International Journal of Cancer
|
September 8, 2004
Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India
Rengaswamy Sankaranarayanan, Ramdas Chatterji, Surendra S Shastri, et al.
International Journal of Cancer
|
April 9, 2005
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
Rengaswamy Sankaranarayanan, Bhagwan M Nene, Ketayun A Dinshaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2022
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences
Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, et al.
Journal of the National Cancer Institute. Monographs
|
November 12, 2024
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination
Sylla G Malvi, Pulikkottil O Esmy, Richard Muwonge, et al.
Plos One
|
December 29, 2020
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study
Richard Muwonge, Partha Basu, Tarik Gheit, et al.
The Lancet. Oncology
|
October 11, 2021
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
Partha Basu, Sylla G Malvi, Smita Joshi, et al.
Vaccine
|
November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Smita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
JCO Global Oncology
|
September 26, 2022
Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update
Surendra S Shastri, Sarah Temin, Maribel Almonte, et al.
The Lancet Regional Health. Southeast Asia
|
December 11, 2023
Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study
Naren Babu, Shakuntala Mahilkar, Anup Jayaram, et al.
The New England Journal of Medicine
|
April 3, 2009
HPV screening for cervical cancer in rural India
Rengaswamy Sankaranarayanan, Bhagwan M Nene, Surendra S Shastri, et al.
International Journal of Cancer
|
September 8, 2004
Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India
Rengaswamy Sankaranarayanan, Ramdas Chatterji, Surendra S Shastri, et al.
International Journal of Cancer
|
April 9, 2005
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
Rengaswamy Sankaranarayanan, Bhagwan M Nene, Ketayun A Dinshaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 9, 2022
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences
Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, et al.
Journal of the National Cancer Institute. Monographs
|
November 12, 2024
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination
Sylla G Malvi, Pulikkottil O Esmy, Richard Muwonge, et al.
Plos One
|
December 29, 2020
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study
Richard Muwonge, Partha Basu, Tarik Gheit, et al.
The Lancet. Oncology
|
October 11, 2021
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
Partha Basu, Sylla G Malvi, Smita Joshi, et al.
Vaccine
|
November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Smita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
Page
of 14